A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization
Clinical trial NCT00220415 · COMPLETED
Trial details
- NCT number
- NCT00220415
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2006-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.